Clinical Trial Update: A Study of LCAR-HL30 in Subjects With Relapsed/Refractory Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating LCAR-HL30 in adults with relapsed or refractory Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Large Cell Lymphoma
• Hodgkin Lymphoma

Drugs mentioned

• LCAR-HL30

Snippet

Sponsor: Ruijin Hospital | Conditions: Hodgkin's Lymphoma, Anaplastic Large Cell Lymphoma | Phase 1 | Status: RECRUITING